Paul J. Clancy

2017

In 2017, Paul J. Clancy earned a total compensation of $3.7M as Former Executive Vice President, Finance and Chief Financial Officer at Biogen, a 32% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$61,983
Salary$458,945
Stock Awards$2,961,929
Other$168,361
Total$3,651,218

Clancy received $3M in stock awards, accounting for 81% of the total pay in 2017.

Clancy also received $62K of change in pension value and nonqualified deferred compensation earnings, $458.9K in salary and $168.4K in other compensation.

Rankings

In 2017, Paul J. Clancy's compensation ranked 2,876th out of 14,666 executives tracked by ExecPay. In other words, Clancy earned more than 80.4% of executives.

ClassificationRankingPercentile
All
2,876
out of 14,666
80th
Division
Manufacturing
987
out of 5,770
83rd
Major group
Chemicals And Allied Products
263
out of 2,074
87th
Industry group
Drugs
201
out of 1,730
88th
Industry
Biological Products, Except Diagnostic Substances
37
out of 316
88th
Source: SEC filing on April 27, 2018.

Clancy's colleagues

We found eight more compensation records of executives who worked with Paul J. Clancy at Biogen in 2017.

2017

Michel Vounatsos

Biogen

Chief Executive Officer

2017

George Scangos

Biogen

Chief Executive Officer

2017

Kenneth DiPietro

Biogen

Former Executive Vice President, Human Resources

2017

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2017

Susan Alexander

Biogen

Chief Legal Officer

2017

Paul McKenzie

Biogen

Executive Vice President, Pharmaceutical Operations & Technology

2017

Gregory Covino

Biogen

Chief Accounting Officer

2017

Jeffrey Capello

Biogen

Chief Financial Officer

You may also like